Story perspectives
Retail Investors Hold Power in Zhejiang Pharma's Ownership
1/1/2025
50 8
1 of 1
Story summary
- Zhejiang Xianju Pharmaceutical Co. has 52% ownership by retail investors and 27% by institutions.
- The largest shareholder, Zhejiang Xianju Development Holdings Co., holds 22%.
- No individual has majority control, and insider ownership details remain unclear.
- Retail investors can impact decisions on dividends and director appointments.
- Analyzing ownership structure is essential for evaluating investment risks.
